US regulators have recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine, as they investigate rare blood clotting in six women.
US regulators have recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine, as they investigate rare blood clotting in six women.